[French specificities in the history of vaccination. The end of an exception?].
Five years after the National Health minister launched the vaccination program against hepatitis B in 1994, French public health experts are not satisfied by the coverage rate among young people. Is this stagnation related to the controversial way the program was initially managed and to the debate that has raged on the link between the vaccine and multiple sclerosis? Is the popular reaction of distrust specific to the vaccine or does it reveal a growing concern towards the whole vaccinal enterprise? More generally, is it the end of the almost unconditional French acceptance of vaccines? A historical retrospective on the history of vaccination in the country of Louis Pasteur.
Moulin
A M
AM
Centre d'études et de documentation économiques et juridiques (CEDEJ-CNRS), Le Caire, Ambassade de France en Egypte, Paris 7. moulin@cedej.org.eg
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D001500:BCG Vaccine / Q000266:history; D002648:Child; D004739:England; D005602:France; D005858:Germany; D006509:Hepatitis B / Q000517:prevention & control*; D017325:Hepatitis B Vaccines / Q000008:administration & dosage / Q000009:adverse effects / Q000266:history*; D049671:History, 18th Century; D049672:History, 19th Century; D049673:History, 20th Century; D006801:Humans; D009103:Multiple Sclerosis / Q000209:etiology; D023321:Poliovirus Vaccines / Q000266:history; D018570:Risk Assessment; D014481:United States; D014611:Vaccination / Q000266:history*
D001500:BCG Vaccine; D017325:Hepatitis B Vaccines; D023321:Poliovirus Vaccines